|
Larrea L, Calabuig M, Roldán V, Rivera J, Tsai HM, Vicente V, Roig R. The influence of riboflavin photochemistry on plasma coagulation factors. Transfus Apher Sci. 2009 Dec;41(3):199-204. doi: 10.1016/j.transci.2009.09.006. Epub 2009 Sep 25. PubMed PMID: 19782644; PubMed Central PMCID: PMC3158998.
AÑO: 2009; IF: 0.938
|
19782644
|
Pérez-Andreu V, Roldán V, González-Conejero R, Hernández-Romero D, Vicente V, Marín F. Implications of pharmacogenetics for oral anticoagulants metabolism. Curr Drug Metab. 2009 Jul;10(6):632-42. PubMed PMID: 19799531.
AÑO: 2009; IF: 3.989
|
|
Jerez A, Fernández A, Osma MM, Roldán V, Ortuño FJ, Vicente V. Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases. Leukemia. 2010 Mar;24(3):640-2. doi: 10.1038/leu.2009.229. Epub 2009 Nov 5. PubMed PMID: 19890376.
AÑO: 2010; IF: 8.966
|
|
Tello-Montoliu A, Marín F, Roldán V, Lip GY. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? Heart. 2010 Feb;96(3):227-8; author reply 228. doi: 10.1136/hrt.2009.182105. PubMed PMID: 20133421.
AÑO: 2010; IF: 4.708
|
|
Pérez-Andreu V, Roldán V, López-Fernández MF, Antón AI, Alberca I, Corral J, Montes R, García-Barberá N, Ferrando F, Vicente V, González-Conejero R. Pharmacogenetics of acenocoumarol in patients with extreme dose requirements. J Thromb Haemost. 2010 May;8(5):1012-7. doi: 10.1111/j.1538-7836.2010.03800.x. Epub 2010 Feb 9. PubMed PMID: 20149073.
AÑO: 2010; IF: 5.439
|